These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9406003)

  • 1. Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer.
    Romics I; Frang D; Bodrogi I
    Int Urol Nephrol; 1997; 29(4):449-55. PubMed ID: 9406003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of studies of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hypertrophy and prostatic cancer].
    Romics I; Bodrogi I; Frang D
    Orv Hetil; 1995 Jul; 136(30):1599-602. PubMed ID: 7543669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patients with diseases of the prostate using prostate-specific antigen density.
    Wolff JM; Boeckmann W; Effert PJ; Handt S; Jakse G
    Br J Urol; 1995 Jul; 76(1):41-6. PubMed ID: 7544203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of benign prostatic hyperplasia and prostate cancer employing prostatic-specific antigen density.
    Wolff JM; Scholz A; Boeckmann W; Jakse G
    Eur Urol; 1994; 25(4):295-8; discussion 304. PubMed ID: 7519991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C; Lein M; Jung K; Schnorr D; Loening SA
    Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
    van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
    Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen.
    Aus G; Bergdahl S; Hugosson J; Lodding P; Norlén L
    Scand J Urol Nephrol; 1994 Dec; 28(4):379-84. PubMed ID: 7533925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
    Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
    Semjonow A; Hamm M; Rathert P; Hertle L
    Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer.
    Clements R; Etherington RJ; Griffiths GJ; Peeling WB; Hughes H; Penney MD
    Br J Urol; 1992 Aug; 70(2):183-7. PubMed ID: 1382795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
    Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
    Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of PSA-density in differential diagnosis between BPH and early stages prostate cancer].
    Uno H
    Nihon Hinyokika Gakkai Zasshi; 1995 Dec; 86(12):1776-83. PubMed ID: 8717220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum prostate-specific antigen and calculated epithelial volume.
    Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
    Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of finasteride on prostate-specific antigen density.
    Gormley GJ; Ng J; Cook T; Stoner E; Guess H; Walsh P
    Urology; 1994 Jan; 43(1):53-8; discussion 58-9. PubMed ID: 7506854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
    Bare R; Hart L; McCullough DL
    Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.